Heart Ailment

Poor sleep is associated with up to seven years worth of increased heart disease risk and even premature death, according to a study. The research, published in the journal BMC Medicine, analysed data from more than 300,000 middle-aged adults from the UK Biobank. Researchers from the University of Sydney in collaboration with Southern Denmark University found that different disturbances to sleep are associated with different durations of compromised cardiovascular health later in life compared to healthy sleepers. In particular, men with clinical sleep-related breathing disorders lost nearly seven years of cardiovascular disease-free life compared to those without these conditions, and women lost over seven years, they said. The study found that even general poor sleep, such as insufficient sleep, insomnia, snoring, going to bed late, and daytime sleepiness is associated with a loss of around two years of normal heart health in men and women. "Our research shows that, over time, .

Pharmaceuticals firm Lupin Ltd on Tuesday said it has received approval from the US health regulator for its generic version of Prasugrel tablets. The medicine is indicated to prevent other serious heart and blood vessel problems in patients with recent heart attacks, strokes and blood clots in stents. The approval by the US Food and Drug Administration (US FDA) for the Abbreviated New Drug Application (ANDA) of Prasugrel tablets of strengths 5 mg and 10 mg, the company said in a regulatory filing. These are the generic equivalent of Effient tablets, 5 mg and 10 mg of Cosette Pharmaceuticals, Inc. "The product will be manufactured at Lupin's facility in Goa, India," it added. Prasugrel Tablets 5 mg and 10 mg had estimated annual sales of USD 18 million in the US, Lupin said citing IQVIA MAT September 2022 data.

The risk of death from heart attack or failure after Covid-19 is very high within the first 30 days of infection, but remains heightened for some time afterwards, a new research has revealed

The findings of a large study of French adults suggest a potential direct association between higher artificial sweetener consumption and increased cardiovascular disease risk, including heart attacks

The study, which was published on August 11, advises patients with Covid-19 history to pay attention to their cardiovascular health

Air pollution may have detrimental effects on heart in individuals with hypertension and kidney disease, according to a study. The researchers found that in adults with chronic kidney disease (CKD) in addition to hypertension, air pollution exposure was associated with rising levels of Galectin 3, a marker of scarring in the heart. The findings were presented online at the American Society of Nephrology (ASN) Kidney Week 2021 on Thursday. "Air pollution may be directly linked to the development of myocardial fibrosis in individuals with CKD," said study lead author Hafsa Tariq, from Case Western Reserve University in the US. Myocardial fibrosis arises when a type of cell in the heart called fibroblasts produce collagenous scar tissue. It can lead to heart failure and death. "Efforts to limit air pollution could have a beneficial effect on lowering subclinical cardiovascular disease in CKD," Tariq said. Satellite-derived measurements of smaller particulate matter, PM2.5, were link

Balloon angioplasty using IVUS, has proved to be successful on heart patients with kidney ailments and diabetes, for Kerala-based Meditrina Hospital

Aaradhya suffers with a hole in her heart and surgery for her treatment comes at an exorbitant price